期刊文献+

血清降钙素原在老年支气管肺炎中的诊疗价值 被引量:4

Value of serum procalcitonin in the diagnosis and treatment of senile bronchial pneumonia in the elderly patients
原文传递
导出
摘要 目的通过测定支气管肺炎患者血中降钙素原(PCT)的含量变化,探讨其在老年支气管肺炎患者中的诊疗价值。方法选择安徽阜阳市人民医院老年科2013年1月至2014年10月住院老年细菌性支气管肺炎患者35例为肺炎组。分别于治疗前、抗生素应用2 d、5 d后行PCT、白细胞(WBC)计数的检测。并选择健康人群(符合非感染人群)25例作为对照组。结果 (1)肺炎组治疗前PCT、WBC计数与对照组比较均有升高,差异有统计学意义(P<0.05)。(2)肺炎组有效治疗后PCT水平有显著的动态下降,治疗前后比较差异有统计学意义(P<0.05)。(3)肺炎组治疗前、后WBC计数差异无统计学意义(P>0.05)。(4)肺炎组患者PCT水平皆大于临界值(0.05 ng/ml),敏感率达100%,WBC计数有27例大于临界值(10×109/L),敏感率达77%。(5)35例中有4例演变为重症肺炎(死亡2例),其PCT水平入院后明显增高且高居不下,而WBC计数无上述特点。结论老年肺炎患者血清PCT检测对其诊断、疗效评价及预后判断有重要意义,且敏感性优于WBC计数。 Objective To study the value of serum procalcitonin( PCT) in the diagnosis and treatment of senile bronchial pneumonia in the elderly patients. Methods Thirty-five elderly patients with bacterial bronchopneumonia in the department of geriatrics of Fuyang People's Hospital from January 2013 to October 2014 were enrolled in this study. The levels of PCT and WBC count were measured before the treatment,two days or five days after using antibiotics. Twenty-five healthy people were enrolled as control group. Results( 1) The levels of PCT and WBC in the pneumonia group before treatment were significantly higher than those in control group( P 0. 05).( 2) After treatment,the level of PCT was significantly decreased in the pneumonia group( P 0. 05).( 3) After treatment,the changes of the level of WBC count was not significant in the pneumonia group( P 0. 05).( 4) The level of PCT of the selected 35 patients in the pneumonia group was higher than the critical value( 0. 05 ng / ml) with a sensitive rate of 100%,meanwhile the level of WBC count of 27 patients was over the critical value( 10 × 109/ L) with a sensitive rate of 77%.( 5) Of the 35 patients,4 suffered from severe pneumonia( and 2 die),and the level of PCT remained at a high level,while WBC counts did not show such characteristics. Conclusions Serum PCT is of great importance in the diagnosis,efficacy evaluation and prognosis for bronchial pneumonia with better susceptibility than WBC count.
作者 章邱东
出处 《实用老年医学》 CAS 2015年第10期867-869,共3页 Practical Geriatrics
关键词 支气管肺炎 老年人 降钙素原 bronchial pneumonia aged procalcitonin
  • 相关文献

参考文献9

二级参考文献86

  • 1王泽宇,吴允孚.C反应蛋白检测在治疗呼吸机相关性肺炎中的作用[J].实用老年医学,2013,27(1):38-40. 被引量:22
  • 2储诚兵,王继芳,王岩,卢士壁,周勇刚,蔡谞.生化检查对人工髋关节感染的诊断价值[J].中华医院感染学杂志,2006,16(4):403-405. 被引量:16
  • 3成人严重感染与感染性休克血流动力学监测与支持指南[J].中华急诊医学杂志,2007,16(2):121-126. 被引量:69
  • 4俞娅芬,陈德昌,宋秀琴.早期诊断严重脓毒症 脓毒性休克研究进展[J].中国急救医学,2007,27(2):154-156. 被引量:56
  • 5Mirjam Christ-Crain, Beat Miiller. Procalcitonin in bacterial infections-hype, hope, more or less [J]? Swiss Med Wkly, 2005, 135: 451--460.
  • 6Muller B, White JC, Nylen E, et al. Ubiquitous expression of the ealcitortin-1 gene in multiple tissues in response to sepsis [J]. J Clin Endocrinol Metab, 2001, 86: 396-404.
  • 7Philippe Linseheid, Dalma Seboek, Eric S. Nylen, et al. In Vitro and in Vivo Caleitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue [J]. Endocrinology, 2003, 144: 5578-5584.
  • 8Meisner M., Procalcitonin (PCT) A new, innovative infection parameter.; Biochemical and clinical aspects; ISBN: 3-13- 105503-0 [S]. Thieme Stuttgart, New York, 2000.
  • 9Mirjam Christ-Crain, Dalana Stolz, Roland Bingisser, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia [J]. American journal of respiratory and critical care medicine, 2006, 174: 84-93.
  • 10Daiana Stolz, Miriam Christ-Crain, Roland Bingisser, et al. Antibiotic Treatment of Exacerbations of COPD [J]. Chest, 2007, 1 : 9-19.

共引文献211

同被引文献34

  • 1郭向华,郭润华,宋志军.卡介苗对慢性绿脓杆菌性肺炎大鼠细胞因子的调节作用[J].现代中西医结合杂志,2005,14(16):2101-2102. 被引量:2
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3072
  • 3谭广,王忠裕.白细胞介素-23的研究进展[J].国际检验医学杂志,2006,27(10):894-895. 被引量:2
  • 4艾启俊,于庆华,张红星,张馨如,刘一倩,瓢金港.PCR技术检测编码绿脓杆菌外毒素A基因[J].中国食品学报,2006,6(6):117-120. 被引量:15
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8245
  • 6Stockley RA. Progression of chronic obstructive pulmonary disease: impact of inflarmnation, comorbidities and therapeutic intervention [ J ]. Curr Med Res Opin, 2009, 25(5) :1235-1245.
  • 7Rosenberg AR, Skapek SX, Hawkins DS. The inconvenience of convenience cohorts : rhabdomyosar- coma and the PAX-FOXO1 biomarker[ J]. Cancer Epidemiol Bi- omarkers Prey, 2012, 21 (7) :1012-1018.
  • 8Daniels JM, Schoorl M, Snijders D, et al. Procalcitonin vs C-reactive pro- tein as predictive markers of response to antibiotic therapy in acute exacer- bations of COPD [ J]. Chest, 2010, 138(5) :1108-1115.
  • 9Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract in- fections in "real life": an interna- tional, multicenter poststudy survey (ProREAL) [J]. Arch Intern Med, 2012, 172(9) :715-722.
  • 10Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care [ J ]. Archives of internal medi- cine, 2008, 168(18) :2000-2008.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部